Stevens-Johnson syndrome associated with abacavir therapy

被引：13

作者：

Bossi, P

Roujeau, JC

Bricaire, F

Caumes, E

机构：

[1] Hop La Pitie Salpetriere, Dept Infect Dis, F-75651 Paris 13, France

[2] Univ Paris 12, Dept Dermatol, Henri Mondor Hosp, Creteil, France

来源：

CLINICAL INFECTIOUS DISEASES | 2002年 / 35卷 / 07期

关键词：

D O I：

10.1086/342571

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：902 / 902

页数：1

共 3 条

[1] CUTANEOUS DISEASE AND DRUG-REACTIONS IN HIV-INFECTION [J].

COOPMAN, SA ;

JOHNSON, RA ;

PLATT, R ;

STERN, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (23) :1670-1674

[2] Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis [J].

Fagot, JP ;

Mockenhaupt, M ;

Bouwes-Bavinck, JN ;

Naldi, L ;

Viboud, C ;

Roujeau, JC .

AIDS, 2001, 15 (14) :1843-1848

[3] Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir [J].

Hetherington, S ;

McGuirk, S ;

Powell, G ;

Cutrell, A ;

Naderer, O ;

Spreen, B ;

Lafon, S ;

Pearce, G ;

Steel, H .

CLINICAL THERAPEUTICS, 2001, 23 (10) :1603-1614

← 1 →